menu
    • menu

    Company profile for ImmunoScape

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ImmunoScape enables the characterization of a patient’s immune profile at unprecedented resolution. Our assays provide a view into the immune system in action, directly observing T cell phenotype & function with simultaneous tracking of TCR-antigen binding. Our platform delivers key insights on antigen-specific T cells in studies of immune checkpoint blockade, therapeutic and prophylactic vaccines, and T cell therapy, empow...
    ImmunoScape enables the characterization of a patient’s immune profile at unprecedented resolution. Our assays provide a view into the immune system in action, directly observing T cell phenotype & function with simultaneous tracking of TCR-antigen binding. Our platform delivers key insights on antigen-specific T cells in studies of immune checkpoint blockade, therapeutic and prophylactic vaccines, and T cell therapy, empowering researchers and drug developers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ImmunoScapeSingapore Flag
    Country
    Country
    Singapore
    Address
    Address
    1 Scotts Road #24-10
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://immunoscape.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Immunoscape Reveals In-Vivo Cell Therapy Expansion Data At AACR
    Immunoscape Reveals In-Vivo Cell Therapy Expansion Data At AACR

    21 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-21/immunoscape-presents-data-on-significant-selective-in-vivo-expansion-of-cell-therapy-product-at-aac

    PHARMIWEB
    21 Apr 2026
    Share Share
    ImmunoScape Inks MOU for Trial with Top U.S. Cancer Center
    ImmunoScape Inks MOU for Trial with Top U.S. Cancer Center

    04 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-04/immunoscape-announces-memorandum-of-understanding-for-clinical-trial-with-premier-us-cancer-center

    PHARMIWEB
    04 Mar 2026
    Share Share
    ImmunoScape Advances Next-Gen Cell Therapy, Adds Key Leaders
    ImmunoScape Advances Next-Gen Cell Therapy, Adds Key Leaders

    13 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251113268855/en/Singapore-based-ImmunoScape-Pioneers-Next-Generation-Cell-Therapy-for-Solid-Tumors-Announces-Key-Licensing-Deal-New-Board-and-SAB-Appointments

    BUSINESSWIRE
    13 Nov 2025
    Share Share
    Cue Bio & Immunoscape Partner For Solid Tumor Cell Therapy
    Cue Bio & Immunoscape Partner For Solid Tumor Cell Therapy

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3182503/0/en/Cue-Biopharma-and-ImmunoScape-Announce-Strategic-Collaboration-to-Develop-Breakthrough-Cell-Therapy-Approach-for-Solid-Tumors.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    ImmunoScape Partners with Singapore’s Experimental Drug Development Centre
    ImmunoScape Partners with Singapore’s Experimental Drug Development Centre

    21 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231221788895/en

    BUSINESSWIRE
    21 Dec 2023
    Share Share
    ImmunoScape and MiNK Collaborate to Accelerate Novel TCR Identification
    ImmunoScape and MiNK Collaborate to Accelerate Novel TCR Identification

    20 Dec 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/12/20/2799174/0/en/ImmunoScape-and-MiNK-Therapeutics-Collaborate-to-Accelerate-Novel-TCR-Identification-and-Therapeutic-Development.html

    GLOBENEWSWIRE
    20 Dec 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search